by
Barbara Kram, Editor | October 10, 2005
Rockville, Maryland, September 23, 2005 -- DrFirst's award-winning Rcopia electronic prescribing solution has been chosen by the State of Delaware for a collaborative pilot program that will target 100 physicians to promote the adoption and use of electronic prescribing technology. While the program will benefit all patients, the focus is on improving patient safety, reducing costs and improving the overall quality of care in the delivery of prescription drug benefits to the state's employees and beneficiaries. Electronic prescribing helps accomplish this through increased decision support for providers at the point-of-prescribing and better communication and connectivity between physicians, pharmacies and payer organizations.
Through the program, DrFirst will recruit 100 high prescribing providers who provide services in the state of Delaware and issue DrFirst Rcopia ePrescribing licenses, handheld PDA devices, WiFi wireless network hardware and ePocrates Rx Pro software. To further enhance rapid adoption, DrFirst will also offer a full patient demographic data upload, training, implementation, and workflow consulting services to participating practices.
"The Medical Society of Delaware is committed to pursuing and promoting new technologies in the name of quality improvement, patient safety, and enhanced efficiency," said James P. Marvel, Jr., M.D., President of the Medical Society of Delaware. "Electronic prescription technology has many benefits to physicians, pharmacists and patients, the most important of which is the potential for increased patient safety. We are excited to be at the forefront of helping to support usage of this new application."

Ad Statistics
Times Displayed: 45539
Times Visited: 1299 Ampronix, a Top Master Distributor for Sony Medical, provides Sales, Service & Exchanges for Sony Surgical Displays, Printers, & More. Rely on Us for Expert Support Tailored to Your Needs. Email info@ampronix.com or Call 949-273-8000 for Premier Pricing.
DrFirst will provide its Rcopia Insight reporting tool and consulting services to deliver deep analysis of the actual results of the program and its impact in key areas. The program will evaluate success based on the ability of electronic prescribing to enhance patient safety through decreased adverse drug events, increased formulary compliance and improved efficiencies in the prescription writing process. Improvements in these areas are expected to lower healthcare costs while improving the general quality of care.
"We applaud the State of Delaware for recognizing the value and power of electronic prescribing and for their commitment to ensure that physicians and employees realize the many benefits that our system brings to the healthcare community," said G. Cameron Deemer, senior VP and GM of DrFirst.